X-133754180-T-TA
Variant names:
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2
The NM_004484.4(GPC3):c.338-5dupT variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.017 ( 23 hom., 186 hem., cov: 19)
Exomes 𝑓: 0.076 ( 1 hom. 18 hem. )
Consequence
GPC3
NM_004484.4 splice_region, intron
NM_004484.4 splice_region, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.883
Publications
7 publications found
Genes affected
GPC3 (HGNC:4451): (glypican 3) Cell surface heparan sulfate proteoglycans are composed of a membrane-associated protein core substituted with a variable number of heparan sulfate chains. Members of the glypican-related integral membrane proteoglycan family (GRIPS) contain a core protein anchored to the cytoplasmic membrane via a glycosyl phosphatidylinositol linkage. These proteins may play a role in the control of cell division and growth regulation. The protein encoded by this gene can bind to and inhibit the dipeptidyl peptidase activity of CD26, and it can induce apoptosis in certain cell types. Deletion mutations in this gene are associated with Simpson-Golabi-Behmel syndrome, also known as Simpson dysmorphia syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2009]
GPC3 Gene-Disease associations (from GenCC):
- Simpson-Golabi-Behmel syndromeInheritance: XL Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- Simpson-Golabi-Behmel syndrome type 1Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -16 ACMG points.
BP6
Variant X-133754180-T-TA is Benign according to our data. Variant chrX-133754180-T-TA is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 695314.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0171 (1305/76406) while in subpopulation AFR AF = 0.0461 (951/20630). AF 95% confidence interval is 0.0437. There are 23 homozygotes in GnomAd4. There are 186 alleles in the male GnomAd4 subpopulation. Median coverage is 19. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 23 XL gene
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0171 AC: 1308AN: 76415Hom.: 23 Cov.: 19 show subpopulations
GnomAD3 genomes
AF:
AC:
1308
AN:
76415
Hom.:
Cov.:
19
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0845 AC: 6102AN: 72176 AF XY: 0.00 show subpopulations
GnomAD2 exomes
AF:
AC:
6102
AN:
72176
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0761 AC: 59912AN: 787248Hom.: 1 Cov.: 0 AF XY: 0.0000922 AC XY: 18AN XY: 195282 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
GnomAD4 exome
AF:
AC:
59912
AN:
787248
Hom.:
Cov.:
0
AF XY:
AC XY:
18
AN XY:
195282
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
AC:
1733
AN:
18655
American (AMR)
AF:
AC:
951
AN:
24986
Ashkenazi Jewish (ASJ)
AF:
AC:
1010
AN:
15120
East Asian (EAS)
AF:
AC:
1429
AN:
25423
South Asian (SAS)
AF:
AC:
1908
AN:
37129
European-Finnish (FIN)
AF:
AC:
1563
AN:
29842
Middle Eastern (MID)
AF:
AC:
142
AN:
2804
European-Non Finnish (NFE)
AF:
AC:
48682
AN:
598847
Other (OTH)
AF:
AC:
2494
AN:
34442
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.304
Heterozygous variant carriers
0
4392
8785
13177
17570
21962
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
2076
4152
6228
8304
10380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0171 AC: 1305AN: 76406Hom.: 23 Cov.: 19 AF XY: 0.0104 AC XY: 186AN XY: 17820 show subpopulations
GnomAD4 genome
AF:
AC:
1305
AN:
76406
Hom.:
Cov.:
19
AF XY:
AC XY:
186
AN XY:
17820
show subpopulations
African (AFR)
AF:
AC:
951
AN:
20630
American (AMR)
AF:
AC:
36
AN:
7245
Ashkenazi Jewish (ASJ)
AF:
AC:
5
AN:
1946
East Asian (EAS)
AF:
AC:
8
AN:
2597
South Asian (SAS)
AF:
AC:
3
AN:
1679
European-Finnish (FIN)
AF:
AC:
31
AN:
2824
Middle Eastern (MID)
AF:
AC:
1
AN:
124
European-Non Finnish (NFE)
AF:
AC:
253
AN:
37899
Other (OTH)
AF:
AC:
13
AN:
1000
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
46
93
139
186
232
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:4
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Hereditary cancer-predisposing syndrome Benign:1
Feb 24, 2020
Sema4, Sema4
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:curation
- -
Wilms tumor 1 Benign:1
Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Simpson-Golabi-Behmel syndrome type 1;CN033288:Wilms tumor 1 Benign:1
Jan 06, 2022
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.